Table 1 The characteristics of women with and without PE in the training set.
From: Pre conception dyslipidemia and risk for preeclampsia in women undergoing IVF ET
PE (n = 266) | No PE (n = 2022) | P | |
|---|---|---|---|
Maternal age, years | 34.0 ± 3.3 | 34.4 ± 3.6 | 0.097 |
Pre-pregnancy BMI, kg/m2 | 23.4 ± 3.3 | 21.9 ± 2.9 | <0.001 |
Pre-pregnancy systolic BP, mmHg | 115.3 ± 10.4 | 113.6 ± 9.3 | 0.006 |
Pre-pregnancy diastolic BP, mmHg | 71.5 ± 6.8 | 70.2 ± 6.6 | 0.004 |
Primiparous, n(%) | 258 (97.0) | 1933 (95.6) | 0.289 |
Twin pregnancy, n(%) | 147(55.3) | 528(26.1) | <0.001 |
Chronic hypertension, n(%) | 38(14.3) | 42(2.1) | <0.001 |
Diabetes mellitus, n(%) | 16(6.0) | 60(3.0) | 0.009 |
Gestational diabetes mellitus | 77(29.0) | 633(31.3) | 0.434 |
Autoimmune diseases, n(%) | 7(2.6) | 53(2.6) | 0.992 |
Time at delivery, gestational weeks | 36.0 ± 2.6 | 38.0 ± 2.4 | < 0.001 |
Glucose, mmol/L | 4.9 ± 0.6 | 4.9 ± 0.6 | 0.543 |
TC, mmol/L | 4.5 ± 0.9 | 4.4 ± 0.8 | 0.037 |
TG, mmol/L | 1.6 ± 1.4 | 1.2 ± 0.7 | <0.001 |
HDL-C, mmol/L | 1.3 ± 0.3 | 1.4 ± 0.3 | 0.002 |
LDL-C, mmol/L | 2.7 ± 0.8 | 2.6 ± 0.7 | 0.045 |
Basal FSH, MIU/mL | 6.3 ± 3.1 | 6.5 ± 2.9 | 0.441 |
Basal LH, MIU/mL | 4.2 ± 3.3 | 4.3 ± 3.6 | 0.939 |
Basal E2, pmol/L | 189.0 ± 252.7 | 188.3 ± 295.0 | 0.972 |
Etiology of infertility | 0.027 | ||
Tubal factor, n(%) | 88(33.1) | 624(30.9) | |
Endometriosis, n(%) | 14(5.3) | 190(9.4) | |
Anovulation, n(%) | 71(26.7) | 410(20.3) | |
Male factor, n(%) | 55(20.7) | 496(24.5) | |
Unexplained infertility, n(%) | 38(14.3) | 302(14.9) | |
Embryo transfer protocol | <0.001 | ||
Natural cycle, n(%) | 45(16.9) | 602(29.8) | |
HRT cycle, n(%) | 87(32.7) | 385(19.0) | |
OI cycle, n(%) | 10(3.8) | 99(4.9) | |
Fresh cycle, n(%) | 124(46.6) | 936(46.3) | |
Type of embryo transfer | 0.972 | ||
Fresh embryo, n(%) | 124(46.6) | 936(46.3) | |
Frozen-thaw embryo, n(%) | 142(53.4) | 1086(53.7) | |
Stage of transferred embryo | 0.61 | ||
Cleavage embryo, n(%) | 174(65.4) | 1286(63.6) | |
Blastocyst, n(%) | 266(34.6) | 736(36.4) |
